Use of SGLT2 Inhibitors Versus DPP-4 Inhibitors and Age-Related Macular Degeneration in Patients WithType 2 Diabetes: A Multinational Cohort Study
In patients with T2DM, those prescribed SGLT2 inhibitors may experience lower risks of AMD and dry AMD compared to those prescribed DPP-4 inhibitors.
Authors
- Chien‐Hsiang Weng (ORCID: https://orcid.org/0000-0002-0794-1263)
- Ssu‐Yu Pan (ORCID: https://orcid.org/0009-0007-4620-1755)
- Jun‐Fu Lin (ORCID: https://orcid.org/0009-0006-5287-7893)
- I‐Jong Wang (ORCID: https://orcid.org/0000-0002-3045-0614)
- Hui‐Ju Lin (ORCID: https://orcid.org/0000-0003-2606-8540)
- Shang-Feng Tsai
- Ching‐Heng Lin
- Chien-Chih Chou
Institutions
- Fu Jen Catholic University (TW)
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- Tunghai University (TW)
- China Medical University (TW)
- Brown University (US)
- Taichung Veterans General Hospital (TW)
- China Medical University Hospital (TW)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1167/iovs.66.4.58
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Novo Nordisk
- Taichung Veterans General Hospital